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ABSTRACT 
Spectroscopic Examination of the Catalytic Decomposition of Hydrogen Peroxide by a 
Copper (II) Complex of a Dissymmetric Schiff Base and an Imidazole Derivative 
by 
John D. Davis, Jr. 
Previous studies involving copper (II) complexed with a dissymmetric Schiff base and 
imidazole derivatives had identified catalase activity of these complexes towards H2O2.  
Reactions such as this are of great interest due to the important role of copper-based 
complexes in biological systems.  Our research has been conducted to add to the base of 
knowledge regarding the efforts of other researchers to investigate copper complexes that 
exhibit similar reactivity as copper-based proteins towards dioxygen.  The copper 
complex chosen for this study contained a tri-dentate Schiff base adduct which, when 
complexed with an imidazole derivative, limited the manner in which peroxo adducts 
could bind while providing distinct spectral peaks which were used to conduct kinetic 
studies.  Our results indicate a reaction mechanism by which the role of the complexed 
copper (II) ion is to activate the peroxo adduct for decomposition through reactions with 
other peroxide molecules, dioxygen, and water. 
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CHAPTER 1 
INTRODUCTION 
 The characterization and investigation of complexes of copper (II) with a 
dissymmetric Schiff base and its imidazole derivatives in previous studies have identified 
several intriguing properties of this family of compounds (1).  One such property of these 
complexes was the observation of catalase activity towards the decomposition of 
hydrogen peroxide in aqueous ethanol solutions (1).  Catalases are biological compounds 
that catalyze chemical reactions under biological conditions (i.e. low temperature, 
aqueous or lipid solvent systems, etc.).  Catalase activity involves reactions of chemical 
compounds that mimic the reactivity of catalases in decomposition reactions.  In the case 
of copper catalases that mediate the catalytic decomposition of hydrogen peroxide, a 
general overall balanced equation for this reaction would be: 
CuCatalase  
2 H2O2   →   2 H2O   +   O2 
 The binding, activation, and metabolism of dioxygen (O2) by copper ions in 
biological systems has spawned extensive research aimed towards deducing the 
fundamental chemistry involved in these reactions.  It is generally accepted that the first 
step in the metabolism of dioxygen in copper-based systems is the reaction of dioxygen 
with a coordinated copper (I) ion to produce a copper (II) peroxo or superoxo 
intermediate (2).  Many metalloproteins that contain copper sites and interact with 
dioxygen have been identified.  Examples of these include hemocyanin, tyrosinase, and 
multicopper oxidases such as laccase, ascorbate oxidase, and ceruloplasm (3).  These 
three multicopper oxidases are known to catalyze the 4-electron reduction of dioxygen to 
water (4). 
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 In an effort to understand the fundamental aspects of the metabolism of dioxygen 
by copper-based proteins, an extensive amount of research has been conducted to 
identify, characterize, and investigate copper complexes that exhibit similar reactivity as 
these copper-based proteins towards dioxygen.  Both mononuclear copper(II) – 
superoxide adducts (5) and peroxo-dicopper(II) complexes have been synthesized, 
characterized, and studied.  In the case of peroxo-copper (II) complexes, four classes of 
compounds have been isolated at low temperatures (-80o C) in solution via the reaction of 
dioxygen with the appropriate copper (I) complexes. Figure 1 provides these four 
structures along with a description of the key characteristics of their spectra. (6) 
 A couple of key observations have been made regarding reactions of copper 
complexes and dioxygen.  One researcher stated, “In every case thus far examined, the 
binding sites of all Cu (II) proteins contribute nitrogenous ligands to the metal ion” (7).  
More specifically, the research conducted to date has indicated that the predominantly 
reactive species were complexes in which two nitrogen atoms were directly coordinated 
to the copper ion (8). 
The second key observation is that the nature and number of ligands coordinated 
to the copper ion plays a critical role both the kinetics and mechanisms of reactions.  
Depending on the nature of the ligands and the overall stereochemistry of the copper 
complex, both copper (I) and copper (II) oxidation states have been identified as having a 
role in the decomposition of the peroxo-copper (II) intermediates.  One researcher has 
postulated a significant contribution of a peroxo-copper (III) resonance form in this 
reaction (9).  Copper (II) complexes typically show a five-coordinate square pyramidal to 
distorted trigonal bipyramidal geometry with the geometry largely determined by the 
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Figure 1: Four Classes of Peroxy-Copper(II) Complexes (6) 
size, number, and nature of coordinated ligands.  Copper (II) complexes exhibit spectral 
peaks in the range of ~500 – 600 nm that correspond to d-d transitions.  Since d-d 
transitions are not possible in d10 metals, copper (I) complexes do not have spectral peaks 
in the 500 – 600 nm range.  Another method for determining the oxidation state of copper 
is the use of 2,2’-biquinoline.  Biquinoline reacts with Cu(I) ions to produce a pink-
colored complex  while solutions having Cu(II) ions exhibit no color change (9). 
Changes in ligand size have been demonstrated to change the reaction rates of 
catalytic reactions of copper complexes (10) and in the case of peroxo complexes, the 
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number of coordinated ligands plays a role in the orientation of the peroxo oxygen atoms 
in dimeric copper (II) complexes.  If three or fewer coordination sites are occupied, the 
peroxo prefers to bind in a “side-on” orientation with both oxygen atoms coordinated to 
both copper ions.  If four sites are occupied, binding will occur in one of two possible 
“end-on” orientations.  In one case, each oxygen atom will coordinate with separate 
copper ions.  In the other case, both copper ions will coordinate with one oxygen atom 
while the other oxygen atom retains its proton (4). 
Imidazole groups play an important role in dioxygen metabolism when copper is 
complexed by histidine-containing peptides (11).  Imidazole is a five-membered nitrogen 
heterocycle and is an ubiquitous ligand in biological systems.  It coordinates to transition 
metals such as copper via one of the two nitrogen atoms residing in the five-membered 
chain.  It is present in proteins as part of the amino acid histidine side-chain, in nucleic 
acid structures as part of the purine ring of adenine and guanine, and as benzimidazole in 
the vitamin B-12 coenzyme (12). 
 Our research has been conducted to add to the basic knowledge regarding the 
effort to identify, characterize, and investigate copper complexes that exhibit similar 
reactivity as these copper-based proteins towards dioxygen.  Most all of the research in 
this area has involved adding dioxygen to copper(I) complexes and studying the reactions 
of dioxygen with copper ions as it progresses through the various peroxy and superoxy 
forms ultimately to form water and hydroxide.  The focus of this research has been the 
study of peroxy-copper reactions.  Our research has expanded the reactions studied to 
include the investigation of peroxy-peroxy disproportionation reactions that are initiated 
by the involvement of copper(II) complexes.  Hydrogen peroxide has the characteristic of 
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having thermodynamically favorable reactions in which the peroxide species could serve 
as both the oxidizing and reducing agent in a redox reaction in a disproportionation 
reaction.  The following two half-cell reactions demonstrate this property for near 
physiological conditions, i.e., pH ~ 7: 
HO2- + H2O + 2e- ↔ 3 OH- ; -0.828 V , and 
HO2- + OH- ↔ O2 + H2O + 2e- ; 0.076 V 
 The overall balanced equation for this disproportionation reaction is: 
2 HO2- ↔ O2 + 2 OH- 
 The copper complex chosen for this study, [Cu(II)SalPAHP]2 . H2O, contains a 
three-coordinate Schiff base adduct resulting from the reaction between salicylaldehyde 
(Sal) and (1S,2S)-(+)D-1-phenyl-2-amino-1,3-propanediol (PAHP), which, when 
complexed with an imidazole derivative, limits the available coordination sites for peroxo 
binding to one.  This forces the peroxo moiety to bind in an “end-on” orientation.  Figure 
2 depicts the synthesis of the Schiff base and Figure 3 depicts the resulting dimeric 
[Cu(II)SalPAHP]2 . H2O complex when the Schiff base is reacted with copper(II) ions.  
Figure 2: Synthesis of the Schiff Base 
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Figure 3: Reaction of Copper(II) Acetate and Schiff Base to form [Cu(II)SalPAHP]2. H2O 
One of the coordination sites for the Schiff base is a nitrogen atom.  This, coupled 
with the nitrogen coordination atom in the imidazole ring, provides the optimal number 
of two coordinated nitrogen atoms for copper catalase reactivity.  The use of an imidazole 
derivative is not only appropriate due to the presence of imidazoles in biological systems, 
it also provides flexibility in the design of the complex.  Many imidazole derivatives are 
commercially available with a wide variety of substituents.  This family of compounds 
provides a useful tool for investigating the effect of subtle changes in ligands on the 
reactivity of the copper ions. 
While several imidazole derivatives were initially tested, research centered almost 
exclusively on 2-methylimidazole.  Figure 4 shows a representation of the 
Cu(II)SalPAHP.2-MeIm complex used for this study.  This imidazole derivative was  
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Figure 4: Reaction of [Cu(II)SalPAHP]2 . H2O Dimer with 2-Methylimidazole to form 
Cu(II)SalPAHP.2-MeIm 
selected due to its stability in relatively high concentrations of hydrogen peroxide, the 
intensity of the spectral peaks of peroxo intermediates, and the resolution of individual 
peaks.  A kinetic study was conducted on this copper (II) complex in order to propose a 
reaction mechanism for its catalytic decomposition of hydrogen peroxide.  The progress 
of the reaction and the measurement of kinetic initial rates were accomplished via 
electron absorption spectroscopy. 
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CHAPTER 2 
EXPERIMENTAL METHODS 
Instruments, Glassware, and Miscellaneous Materials 
The following instruments, glassware, software, and miscellaneous materials were 
used: Cary 14 UV/Vis/IR spectrometer, Sartoris laboratory balance, Jandel Scientific 
TableCurve, Microsoft Excel, 500 uL glass syringe, 22 gauge syringe needles, 50 mL 
volumetric flasks, 5 mL serological glass pipettes (graduated in 0.01 mL increments), 4 
mL quartz crystal cuvettes, and miscellaneous laboratory glassware such as beakers, 
sample bottles, and graduated cylinders. 
Reagent Grade Stock Chemicals 
Reagent grade salicylaldehyde (Sal), (1S,2S)-(+)D-1-phenyl-2-amino-1,3-
propanediol (PAHPH), copper(II) acetate, imidazole (Im), 4-nitroimidazole (4-NIm), 2-
methylimidazole (2-MeIm), 4-methylimidazole (4-MeIm), ethanol (absolute), 2,2’-
biquinoline, and deionized water were used for testing. 
 Commercially prepared 0.9 M hydrogen peroxide solution (3%, USP grade) was 
used for testing. 
Experimental Approach 
 Previous studies involving reactions of Cu(II)SalPAHP.Im with hydrogen 
peroxide had shown that the progress of the catalytic decomposition of the peroxide by 
the copper complex could be tracked through the formation of a spectrally active 
intermediate (peak at 440 nm).  (1)  A series of preliminary qualitative tests were 
performed in order to define the optimum reagents ranges for conducting a kinetics study 
of this system. 
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 The tests involved the use of various concentrations of [Cu(II)SalPAHP]2 . H2O, 
imidazole derivative, and initial hydrogen peroxide levels.  In addition to varying the 
concentration of imidazole derivatives, four different imidazole derivatives were 
evaluated: imidazole (Im), 4-nitroimidazole (4-NIm), 2-methylimidazole (2-MeIm), and 
4-methylimidazole (4-MeIm). 
 Based on these qualitative tests, the following conditions were selected for the 
kinetic study: 
1. 2-Methylimidazole (2-MeIM) was selected as the imidazole derivative; 
2. 2-MeIm concentration range = 0.001 – 0.005 M; 
3. [Cu(II)SalPAHP]2 . H2O concentrations = 0.0001, 0.0002, and 0.0003 M; 
4. Hydrogen peroxide initial concentration range = 0.00015 – 0.0025 M; and 
5. Solvent was a 60/40 mixture of ethanol and deionized water. 
Kinetics Study 
 A kinetics study was performed in order to attempt to deduce to the mechanism 
by which Cu(II)SalPAHP.2-MeIm catalytically decomposes hydrogen peroxide.  Due to 
the formation of a second peak after about one minute, the kinetics study was performed 
by estimating the initial reaction rate for the first 30 seconds of the reaction.  The initial 
rates were estimated via a previously described mathematical approach using absorbance 
(D) versus time (T) plots. (13, 14, 15)  In this approach, absorbance versus time plots 
were fit to the polynomial equation: 
D = a + bT + cT2 + dT3 + …. 
The first derivative of this expression is: 
dD/dT = b + 2cT + 3dT2 + …. 
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And at T = 0, dD/dT = b 
 Thus “b” provides a good estimate of the initial rate of a reaction.  Absorbance 
versus time plots were developed from the Cary 14 strip-charts for each kinetics test and 
fit to the polynomial equation using TableCurve software. 
 The following steps were followed for each kinetics test.  A volume of 3.0 mL of 
Cu(II)SalPAHP.2-MeIm solution was pipetted into a 4 mL quartz crystal cuvette.  The 
cuvette was placed in the Cary 14.  The desired volume of pre-diluted hydrogen peroxide 
solution (0.05 – 0.25 mL) was added to the cuvette using the glass syringe.  These 
volumes were selected to keep the dilution of the contents of the cuvette to less than 10%.   
The contents of the cuvette were stirred with the syringe for 5 seconds.  The spectrometer 
chart was started after 10 seconds of total elapsed time with the wavelength fixed at 445 
nm.  The first 60 seconds of the reaction was charted.  A time period of 60 seconds was 
chosen based on the observation in the preliminary qualitative tests of the appearance of 
the second intermediate peak.  It was theorized that using some time interval of  less than 
60 seconds would minimize the contribution of the formation of the second intermediate 
to the initial rate attributed to the intermediate being studied at 445 nm. 
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CHAPTER 3 
RESULTS 
Preparation of Cu(II)SalPAHP.2-MeIm 
 The detailed synthesis of [Cu(II)SalPAHP]2 . H2O has been previously described 
(1).  The [Cu(II)SalPAHP]2 . H2O used for this study was prepared by this method.  In 
general, salicylaldehyde is reacted with (1S,2S)-(+)D 1-phenyl-2-amino-1,3-propanediol 
under reflux in ethanol to prepare the Schiff base SalPAHP.  Once recrystalized and 
isolated, a yellow crystalline product is obtained.  Figure 2 depicts the synthesis of the 
Schiff base. 
 The dimeric copper complex is obtained from the reaction of an aqueous solution 
of copper(II) acetate monohydrate with an ethanolic solution SalPAHP.  The resulting 
green product is filtered, re-dissolved in ethanol, and precipitated by addition of water.  
The resulting [Cu(II)SalPAHP]2 . H2O has been well characterized and has been assigned 
the CAS Registry No. 80327-02-2. (1)  Figure 3 depicts the resulting dimeric 
[Cu(II)SalPAHP]2 . H2O complex.  
 Imidazole derivatives of this complex were prepared by adding stoichiometric 
excesses of imidazole derivative to the dimeric [Cu(II)SalPAHP]2 . H2O in ethanol or in 
mixtures of ethanol and deionized water to form solutions of the monomeric 
Cu(II)SalPAHP.Im complex.  For this study, mixtures of 60% ethanol and 40% deionized 
water were typically used.  Tests using ethanol only were also performed.  Typically, the 
[Cu(II)SalPAHP]2 . H2O was first dissolved in ethanol only.  A bright Kelly-green 
solution was obtained.  As the imidazole derivative was added and allowed to stand, a 
purplish-bluish solution formed.  Aliquots of this solution were used for testing. 
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Preparation of “Active” Cu(II)SalPAHP.2-MeIm 
 Initially, the active form of the copper complex was prepared by synthesizing the 
Cu(II)SalPAHP.2-MeIm in the presence of water to produce the greenish-blue species 
described below and testing the samples before the greenish-blue color had decayed away 
to form the final purplish-blue color.  Samples were typically used 2 – 3 hours after 
2_MeIm addition.  Most of the tests were performed using samples prepared in this 
manner. 
 Due to the striking similarity between the spectra from samples of the active 
species as prepared above to the spectra of non-active samples that had been dosed with 
peroxide and allowed to react for about 2 hours, it was theorized that the two species 
were actually the same. 
 This theory was tested by re-dosing several samples that had been treated with 
peroxide and allowed to react for 2 hours.  Absorbance versus time plots were collected 
for these tests and compared to those collected from active samples prepared by 
synthesizing the copper complex in the presence of water.  The spectra from these two 
differently prepared active samples seemed to be the same both in the appearance of the 
plots and in the initial rates that were estimated. 
 Fairly reproducible were obtained despite the somewhat subjective nature involve 
in the preparation of these samples. 
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Preliminary Qualitative Tests 
Qualitative preliminary tests were performed in order to determine the optimum 
reagents ranges for the kinetics tests and for selecting the imidazole derivative to be used 
in the kinetics testing.  Several key observations were made during these initial 
investigations.  The first was that the use of too high of an initial hydrogen peroxide 
dosage would cause in irreversible reaction in which the copper was precipitated.  A 
yellowish-orange precipitate was formed.  No attempt was made in this project to 
characterize this precipitant.  The levels of peroxide that would lead to this undesired 
reaction were not only dictated by the concentration of copper complex but also by the 
level of imidazole derivative present in the sample. 
It was observed that increasing the levels of imidazole while keeping both copper 
and initial peroxide concentrations constant initially led to slightly higher reaction rates, 
reached a maximum rate, and then progressively slowed the overall reaction of the 
peroxide decomposition reaction as higher levels of imidazole were used.  If insufficient 
levels of imidazole derivative were present, the undesired copper precipitation reaction 
would predominate when peroxide was added. 
Other interesting observations resulted from the testing of four different imidazole 
derivatives.  The four derivatives tested were:  imidazole, 4-nitroimidazole, 4-
methylimidazole, and 2-methylimidazole.  The copper complex formed with 4-
nitroimidazole was not stable.  A reaction similar to the one that occurred when too much 
peroxide was added was observed.  The other three derivatives formed clear greenish-
blue solutions that gradually (over about an 8-hour time period) changed into purplish-
blue solutions that remained stable over indefinite periods of time provided the solutions 
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were contained in tightly capped bottles to prevent the evaporation of the ethanol.  It was 
interesting to note that if the Cu(II)SalPAHP.ImD (where “ImD” denotes generic 
imidazole derivative) complexes were prepared in ethanol only, or if the reagents were 
first dissolved in ethanol and then the deionized water was added, the solutions 
immediately became the final purplish-blue hue without going through the time-period in 
which the greenish-blue color grew in and subsequently decayed away.  The pH of these 
solutions were ~7.9.  It was observed that there was not a noticeable change in pH during 
the reaction of the Cu(II)SalPAHP.ImD complexes with peroxide. 
 Solutions of the three stable Cu(II)SalPAHP.ImD complexes that contained the 
same concentrations of copper and imidazole were tested with the same initial dosages of 
peroxide in order to observe the differences in performance for each imidazole derivative.  
The solution containing 2-MeIm yielded the most intense spectra and qualitatively 
seemed to be able to tolerate higher initial dosages of peroxide than the other two 
derivatives.  Careful review of spectra obtained from the preliminary tests revealed that 
there was a second intermediate spectral peak at ~420 nm in addition to the reported peak 
at ~440 nm.  This peak was difficult to detect due to its proximity to the peak at 440 nm 
and that the 420 peak started growing in about 1 minute later than the 440 nm peak.  This 
second peak was most clearly seen when 2-MeIm was used.  For 2-MeIm, the first 
intermediate peak was at 445 nm and the second peak was at 418 nm.  Figure 5 provides 
a series of spectra clearly showing the presence of the two peaks and the order at which 
they appear.  Changes in the shapes of the peaks for solutions containing Im and 2-MeIm 
indicated the presence of this second intermediate; however these two peaks could not be 
resolved for these samples.  Due to the intensity of the intermediates peaks for solutions  
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Figure 5: Spectra for Reaction between Cu(II)SalPAHP.2-MeIm and Hydrogen Peroxide 
Showing the Presence of Two Intermediates* 
 
*Spectra acquired at start times of 1, 3, 5, 7, 9, 11, 13, & 15 minutes.  Scans were started 
at 400 nm and ended at 460 nm.  Chart runs from right to left.  Test conditions were: 
0.0001 M [CuSalPAHP]2; 0.001 M 2-MeIm, and 0.00065 M H2O2 (initial). 
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containing 2-MeIm, the [CuSalPAHP]2 concentration range for the kinetics tests was set 
as 0.0001  - 0.0003 M in order to capture complete absorbance versus time plots.  
Appendix B contains the TableCurve data files referenced in this thesis.  These printouts 
show the polynomial data fit including the polynomial equation, the correlation 
coefficient for the data fit, and the coefficients for the “b” terms, which were used as the 
value for the estimated initial rate of formation of the first intermediate. 
Figure 6 provides a graphical representation of one of the tests run with solutions 
containing the three different imidazole derivatives.  The tabular data for these tests (read 
from the Cary 14 strip-charts) is given in Appendix 1.  It is important to note that the data 
plots in Figure 6 are composite data points from spectra taken at timed intervals and not 
continuous absorbance versus time plots.  They were useful for demonstrating the relative 
magnitude of the formation of the copper complex intermediate but were not used to 
make any conclusions about the timing of when maximum concentrations of 
intermediates were reached.  This is especially relevant in the case of the 2-MeIm 
solution whereby the peak was off-scale for the reading at 7.5 minutes of elapsed time.  
However, continuous absorbance versus time plots were used for the kinetics tests.
23 
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*Im & 4-MeIm intermediate peaks at 448 nm; 2-MeIm intermediate peak at 445 nm. 
 
Kinetics Study 
A series of kinetics tests were performed in order to attempt to deduce to the 
mechanism by which Cu(II)SalPAHP.2-MeIm catalytically decomposes hydrogen 
peroxide.  Initially the initial rate estimation results were very erratic and unpredictable.  
After a great deal of test protocol troubleshooting and review, the problem with data 
consistency was tracked back to sample preparation. 
It was determined that the order of solvent addition played a role in whether or 
not a highly reactive “active” complex was created.  As was noted above, if water was 
present during the reaction of the [CuSalPAHP]2  with 2-MeIm, a greenish-blue 
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intermediate formed that slowly decayed away leaving the typical purplish-blue hue.  
Spectra obtained from copper complexes exhibiting this formation-induced greenish-blue 
intermediate that appeared to be identical to spectra having the characteristic peaks at 418 
and 445 nm obtained when small dosages of peroxide were added to Cu(II)SalPAHP.2-
MeIm solutions.  This would seem to imply that peroxide was created.  It is not presently 
clear by what mechanism this could have occurred. 
It was also observed that once a sample of Cu(II)SalPAHP.2-MeIm  was treated 
with peroxide, allowed to decay until the yellow intermediate at the peak of the reaction 
had decayed to a greenish-blue shade, and retreated with peroxide, that rate results 
similar to those obtained when testing the synthesis-induced greenish-blue samples.  In 
both cases, reaction rates are 4 – 5 times higher for these “active” samples when 
compared to non-active samples with the same concentrations of 2-MeIm and 
[CuSalPAHP]2 .  
It is curious to note that once the purplish-blue Cu(II)SalPAHP.2-MeIm was 
obtained, adding additional water did not recreate the greenish-blue intermediate.  An 
explanation of what is happening during synthesis of Cu(II)SalPAHP.2-MeIm in the 
presence of water that would produce this intermediate has not been deduced at this time. 
The adjustment in the synthesis protocol allowed for reproducible kinetics tests.  
The three variables evaluated during testing were: [CuSalPAHP]2, 2-MeIm, and hydrogen 
peroxide concentrations.  Series of tests were performed in which two variables were held 
constant and one variable was systematically changed.  Tables 1, 2, and 3 provide the 
data from these tests.  In addition to the reagent levels and initial rates estimated from 
TableCurve software, the statistical goodness of fit values (R2), absorbance (D) at 445 nm 
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before peroxide addition, absorbance (D) at 445 nm after 30 seconds of elapsed time, and 
the TableCurve data file number. Appendix 2 contains the printouts for the data files 
referenced in this thesis. 
Table 1: Effect of Varying Initial Hydrogen Peroxide Concentration on Initial Reaction 
Rate (constant [CuSalPAHP]2  and [2-MeIm]) 
[Cu(II)], 
M (10-4) 
[2-MeIm], 
M (10-4) 
[H2O2], 
M (10-4)
k, 
s-1 (10-4)
Dinitial Dt=30s R2 Data 
File 
2.0 30 5 56 0.08 0.16 0.9998 88 
2.0 30 10 93 0.08 0.19 0.9999 87 
2.0 30 15 103 0.08 0.22 0.9999 86 
2.0 30 20 111 0.08 0.24 0.9999 85 
2.0 30 25 121 0.08 0.25 0.9999 82 
2.0 30 25 123 0.08 0.125 0.9998 81 
Table 2: Effect of Varying 2-Methylimidazole Concentration on Initial Reaction Rate 
(constant [CuSalPAHP]2  and [H2O2]) 
[Cu(II)], 
M (10-4) 
[2-MeIm], 
M (10-4) 
[H2O2], 
M (10-4)
k, 
s-1 (10-4)
Dinitial Dt=30s R2 Data 
File 
2.0 20 25 102 0.08 0.22 0.9999 73 
2.0 20 25 97 0.08 0.21 0.9999 79 
2.0 30 25 123 0.08 0.25 0.9998 81 
2.0 30 25 121 0.08 0.25 0.9999 82 
2.0 40 25 98 0.08 0.21 0.9999 75 
2.0 40 25 98 0.08 0.22 0.9999 83 
2.0 50 25 67 0.08 0.16 0.9999 77 
2.0 50 25 56 0.08 0.17 0.9999 78 
Table 3: Effect of Varying [CuSalPAHP]2 Concentration on Initial Reaction Rate 
(constant [2-MeIm]  and [H2O2]) 
[Cu(II)], 
M (10-4) 
[2-MeIm], 
M (10-4) 
[H2O2], 
M (10-4)
k, 
s-1 (10-4)
Dinitial Dt=30s R2 Data 
File 
1.0 30 25 42 0.05 0.11 0.9999 94 
1.0 30 25 37 0.05 0.11 0.9999 95 
2.0 30 25 123 0.08 0.25 0.9999 81 
2.0 30 25 121 0.08 0.25 0.9999 82 
3.0 30 25 317 0.10 0.33 0.9999 96 
3.0 30 25 267 0.10 0.31 0.9998 97 
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Tests were also performed using “active” copper complex samples.  Tables 4, 5, 
and 6 contain the data from these tests.  Due to the somewhat subjective nature of the 
preparation of the active complex, there was a greater degree of variability in data from 
tests run under identical test conditions.  There is an example of this in Table 4 wherein 
two tests run under identical conditions has estimated initial rates of 0.0283 and 0.0340 
sec-1. 
Table 4: Active Copper Complex: Effect of Varying Initial Hydrogen Peroxide 
Concentration on Initial Reaction Rate (constant [CuSalPAHP]2  and [2-MeIm]) 
[Cu(II)], 
M (10-4) 
[2-MeIm], 
M (10-4) 
[H2O2], 
M (10-4)
k, 
S-1 (10-4)
Dinitial Dt=30s R2 Data 
File 
2.0 30 2.9 103 0.08 0.21 0.9999 59 
2.0 30 4.0 137 0.08 0.25 0.9993 58 
2.0 30 5.0 145 0.08 0.28 0.9999 57 
2.0 30 6.6 160 0.08 0.27 0.9998 56 
2.0 30 13 220 0.08 0.34 0.9999 55 
2.0 30 25 283 0.08 0.42 0.9998 54 
2.0 30 25 340 0.08 0.54 0.9999 53 
Table 5: Active Copper Complex: Effect of Varying 2-Methylimidazole Concentration on 
Initial Reaction Rate (constant [CuSalPAHP]2  and [H2O2]) 
[Cu(II)], 
M (10-4) 
[2-MeIm], 
M (10-4) 
[H2O2], 
M (10-4)
k, 
S-1 (10-4)
Dinitial Dt=30s R2 Data 
File 
2.0 25 25 270 0.08 0.42 0.9999 60 
2.0 30 25 340 0.08 0.42 0.9999 53 
2.0 30 25 283 0.08 0.54 0.9998 54 
2.0 40 25 256 0.07 0.41 0.9999 28 
2.0 50 25 188 0.08 0.31 0.9999 23 
2.0 50 25 184 0.07 0.32 0.9999 29 
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Table 6: Active Copper Complex: Effect of Varying [CuSalPAHP]2 Concentration on 
Initial Reaction Rate (constant [2-MeIm]  and [H2O2]) 
[Cu(II)], 
M (10-4) 
[2-MeIm], 
M (10-4) 
[H2O2], 
M (10-4)
k, 
S-1 (10-4)
Dinitial Dt=30s R2 Data 
File 
1.0 30 25 141 0.06 0.28 0.9973 24 
1.0 30 25 162 0.06 0.29 0.9999 48 
2.0 30 25 283 0.08 0.42 0.9998 54 
2.0 30 25 340 0.08 0.54 0.9999 53 
3.0 30 25 436 0.10 0.79 0.9998 25 
 
Figures 7, 8, and 9 contain data from similar evaluations of both active and 
original non-active samples.  Similar trends are present in Figures 7 and 8 (varying initial 
peroxide dosage and varying 2-MeIm concentration).  The trends are different in Figure 9 
however.  The data from the active species is a virtual straight line while the data plot 
from the non-active samples has upward curvature. 
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Figure 7: Effect of Varying Initial Hydrogen Peroxide Concentration on Initial Reaction 
Rate (constant [CuSalPAHP]2 and [2-MeIm]) 
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Figure 8: Effect of Varying 2-Methylimidazole Concentration on Initial Reaction Rate 
(constant [CuSalPAHP]2  and [H2O2]) 
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Figure 9: Effect of Varying [CuSalPAHP]2 Concentration on Initial Reaction Rate 
(constant [2-MeIm]  and [H2O2]) 
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The final piece of missing information was to attempt to answer the question of 
whether or not the copper ions in the Cu(II)SalPAHP.2-MeIm complex are reduced from 
+2 to +1 and then oxidized back to +2 to complete the catalytic cycle.  As previously 
discussed above, two positive indicators of the oxidation state of copper are the presence 
of a spectral peak that can be assigned as a “d-d” transition due to Cu(II) and the color of 
solutions containing copper (I) and biquinoline.  The Cu(II)SalPAHP.2-MeIm complex 
shows a distinct peak at 595 nm that has been assigned as a d-d transition.  Tests were 
performed in which time versus absorbance plots were obtained for the peaks at 418, 445, 
and 595 nm.  Figure 10 presents an overlay of these three plots for one of these tests.  In 
these tests, the peak at 595 nm stayed at nearly the same intensity until after both 
intermediates had decayed mostly away.  There was a point in most cases where the 
intensity of the 595 nm peak would drop about 5 - 10% after ~20 minutes of testing and 
would then start back upwards towards the original intensity. 
In one test, a full spectrum was acquired for the Cu(II)SalPAHP.2-MeIm solution 
before peroxide addition and again when this drop in intensity at 595 nm occurred.  The 
solvent for this sample was ethanol only.  Figure 11 provides these two spectra for 
comparison.  The second spectrum does have a lower peak height at 595 nm, but this 
appears to be compensated for by broadening of the peak.  In any case, there were clearly 
defined d-d transition peaks in all tests throughout each test run. 
Tests were attempted using biquinoline as an indicator for the presence of Cu(I); 
however, when biquinoline was added to solutions of Cu(II)SalPAHP.2-MeIm, the 
solution started turning pink before peroxide could be added.  These tests were 
discontinued. 
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Figure 10: Absorbance Plots at 418, 445, and 595 nm (0.0001 M  [CuSalPAHP]2; 0.003 
M 2-MeIm; 0.0013 M H2O2 (initial)) 
33 
0
0.02
0.04
0.06
0.08
0.1
0.12
0.14
0.16
0.18
500 520 540 560 580 600 620
Wavelength, nm
A
bs
or
ba
nc
e
T=0 Min.
T=20 Min.
 
Figure 11: Spectra of Cu(II)SalPAHP.2-MeIm at T=0 and at T=20 Minutes (0.00025 M  
[CuSalPAHP]2; 0.0075 M 2-MeIm; 0.0013 M H2O2 (initial)) 
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CHAPTER 4 
DISCUSSION 
Preliminary Qualitative Test Results 
The initial hypothesis was that affect of changing imidazole substituents would be 
governed by the different pKa’s of the different derivatives.  This hypothesis was based 
on the belief that hydroxide molecules played a key role in the peroxide decomposition 
reaction.  This trend initially held up as stability to relatively high concentrations of 
peroxide and spectral intensity of the first intermediate increased in the order of: 
imidazole, 4-methylimidazole, and 2-methylimidazole.  However, 4-nitroimidazole, with 
the highest pKa of the imidazole derivatives tested, was unstable.  Precipitation of the 
copper complex was observed almost immediately for samples prepared with 4-NIm.  It 
was not possible to test this complex with peroxide.  Another possible role of the 
imidazole with regards to its affect on CuSalPAHP-Im reactivity is the ability of the 
imidazole group to stabilize the copper in the Cu(II) oxidation state while it is bound to a 
peroxide molecule.  Previous work with copper(II) diethylenetriamine substituted 
imidazole complexes identified a property that the researchers called “apparent binding 
constant, K”.  This property was described as a quantitative measure of the strength of the 
Cu-N bond.  The Apparent Binding Constants followed the trend: 4-methylimidazole, 
and 2-methylimidazole.  A constant was not measured for 4-nitroimidazole.  Table 7 
provides pKa’s and pK’s (binding) for Im, 4-MeIm, and 2-MeIm. (14)  The pKa for 4-
NIm is also included. (15). 
Spectral evidence collected during the preliminary qualitative tests point to the 
existence of two intermediates that have long enough lifetimes to allow for the collection 
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of spectra.  Comparison of the spectra to published spectra and spectral data allow for 
structures to be assigned to the two intermediates.  The first intermediate has been 
assigned Structure II (Figure 1) based on its intense peak at 445 nm.  The second 
intermediate has been assigned Structure IV based on its intense peak at 418 nm.  
Although the position of the peak would allow for selection of Structure I, it was not 
considered because this structure would either require the CuSalPAHP-2-MeIm to be 
hexa-coordinate or would require that one of the other coordinated Cu-O bonds from the 
Schiff base to be broken.  Structure III was not selected because of the need for an intense 
peak in the same region as Structure II along with a less intense peak on the higher 
wavelength shoulder of the primary peak.  This peak shape was not observed in this 
study. 
Table 7: Apparent Binding Constants and pKa’s for Imidazole Derivatives  
Imidazole Derivative pKa pK 
Imidazole 6.90 0.307 
4-Methylimidazole 7.35 -0.084 
2-Methylimidazole 7.77 -0.304 
4-Nitroimidazole 9.20 NA 
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Kinetic Tests Results 
 After reviewing several of the curve-fits, it was apparent that at a point 
somewhere between 30 and 60 seconds the growth of the peak at 418 nm was 
significantly affecting the initial rate estimations.  To minimize this effect, the initial rate 
estimations presented in Tables 1 – 6 are based on the first 30 seconds of the reaction 
after peroxide addition.   
The kinetics tests data indicates the existence of both consecutive and competing 
reactions.  The kinetics tests were designed to allow for comparison plots to be prepared.    
The plot of Cu(II) concentration versus rate (Figure 9) shows that the reaction with 
regards to copper is first order in the case of the active species but appears to be second 
order with respect to copper for the non-active species.  The plot of initial hydrogen 
peroxide concentration versus rate (Figure 7) seems to indicate the presence of a 
maximum level of peroxide dosage that can be handled by a certain concentration of 
copper complex.  Indeed, it was observed that the addition of too much peroxide led to 
the irreversible precipitation of the copper complex.  It is possible that the curve in Figure 
7 represents a composite of saturation of the copper complex with peroxide as peroxide 
dosage was increased and the increased significance of the irreversible precipitation 
reaction for the tests in which the highest peroxide dosages were used.    
 The plot of 2-MeIm versus rate (Figure 8) indicates competing reactions.  
Initially, as the imidazole was increased, reaction rates clearly increased and reached a 
maximum level.  This result was expected because the initial hypothesis for a reaction 
mechanism involved the need for a hydroxide species in the peroxide decomposition 
reaction.  The downward turn in reaction rate as additional 2-MeIm was added past the 
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maximum rate point described above was attributed to increasing competition of the 
excess 2-MeIm for the coordination site on which peroxide bonded.  These two reactions 
would be: 
CuIm + Im ↔ CuIm2 (Equation 4 below) 
CuIm + HO2- → CuIm(HO2-) (Equation 5 below) 
Based on the results from the both the kinetics tests and the scoping tests, the 
following mechanism is proposed (Cu  = CuSalPAHP moiety; Im is generic imidazole): 
 
Eq. 1: Im  + H2O ↔ ImH+ + OH- ; Kb 
Eq. 2: H2O2 + Im ↔ HO2- + ImH+; Ka(H2O2) 
Eq. 3: Cu2 + 2 Im ↔ 2 CuIm; k1 
Eq. 4: CuIm + Im ↔ CuIm2; k2 (competitive reaction that impedes HO2- bonding with 
Cu) 
Eq. 5: CuIm + HO2- →CuIm(HO2-); k3 (I1 formed) 
Eq. 6: I1 + HO2- → CuIm(HO2)22-; k4 (T1 formed) 
Eq. 7: I1 + CuIm → [(CuIm)2HO2-]; k5 (I2 formed) 
Eq. 8: T1 → CuIm + 2 OH- + O2 ; k6 (HO2- on Cu reduced and second HO2- is oxidized) 
Eq. 9: T1 + CuIm → (CuIm)2(HO2)22-; k7 (T2 formed) 
Eq. 10: T2 + OH- → I2 + H2O + O2; k8 
Eq. 11: I2 + HO2-  → 2 I1; k9 (explains higher rate of I1 formation in tests with 
“activated” CuIm) 
Eq. 12: I2 + OH- → (CuIm)2O2 + H2O; k10 (T3 formed) 
Eq. 13:  T3 → 2 CuIm + O2; k11 
Eq. 14: Cu + H2O2 → Cu Ppt; k12 (predominates when too much peroxide is added) 
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 The terms “T1”, “T2”, and “T3” were used to denote what are believed to be 
short-lived transition states.  Figure 13 provides a visual reaction pathway for this set of 
reactions.  Figures 14, 15, and 16 detail each of the three catalytic cycles that make up the 
integrated cycle in Figure 13. 
 This set of reactions provides good explanations for the data and observations 
made in this study.  There is no requirement in the proposed mechanism for the copper to 
change oxidations states, which allows for the fairly constant peak intensity for the 
observed d-d transition.  The 2nd Intermediate, I2, was assigned as the primary reactive 
constituent in the “active” species (results in Tables 4, 5, and 6).  The active species also 
probably contains low concentrations of I1.  Equation 9 provides the explanation of why 
the reaction rates forming the 1st Intermediate, I1, are faster than those for the un-
activated species.  For every mole of peroxide with the I2, two moles of the I1 are 
immediately formed.  The Equation 1 reaction competes with the Equation 2 reaction 
with respect to the formation of the I1 which explain the dual role of 2-MeIm for 
providing hydroxide required to initiate the peroxide decomposition reaction and for 
competing with peroxide molecules for the reactive coordination site on the copper ions. 
  The reaction in Equation 10 provides the greatest contribution to the formation of 
I1 due to the coefficient for I1 concentration (two moles of I1 are formed for every mole 
of I2 present) thus providing an explanation for the observed second order reaction in 
Cu(II) (increasing Cu(II) concentration would be expected to drive the reaction towards 
the Equation 10 route).  If most of the copper is in the “active” state, I2, then the addition 
of increasing levels of Cu(II) would have little effect on the rate of the Equation 11 
reaction (I2 concentration already is high in this case) and would drive the reaction 
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towards the Equation 5 route.  These scenarios satisfy the observations and results 
obtained in testing. 
 In conclusion, a valuable contribution to field of copper chemistry has been made.  
The use of the Schiff base along with the imidazole derivative provided the desired effect 
of forcing the added peroxide molecules to add in the less preferred end-on orientation.  
This provides the research community with a complex that can simulate the chemistry of 
biological catalases that exhibit end-on peroxy-Cu(II) bonding for study.  The use of the 
Schiff base and stabilizing imidazoles also induced the copper complex to remain in the 
Cu(II) state thus forcing the copper(II)-peroxide intermediates to decompose primarily 
through disproportionation reactions with other peroxide molecules and water in the 
solvent system. 
 The study of these reactions has led to an interesting and unique mechanism for 
the catalytic decomposition of hydrogen peroxide and has opened the door to other 
studies involving this family of complexes such as determining the nature of the nitrogen-
copper coordination bond and why the different imidazole derivatives impact the 
peroxide disproportionation reaction, designing copper catalysts with specific properties, 
performing low-temperature studies to extend the lifetimes of the intermediates so that 
the structure of these intermediates can be confirmed, and determining the nature of the 
reaction in which the imidazole reacts with the CuSalPAHP dimer in the presence of 
water to form a reactive peroxide-like intermediate. 
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Figure 12: Integrated Catalytic Cycle 
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Figure 13: Catalytic Cycle – First Pathway 
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Figure 14: Catalytic Cycle – Second Pathway
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Figure 15: Catalytic Cycle – Third Pathway 
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APPENDICES 
Appendix A: Tabular Absorbance Versus Time Date for Initial Evaluation of Imidazole 
Derivatives (with [CuSalPAHP]2 = 0.001 M; [Im Derivative] = 0.01 M; & [H2O2] = 
0.003 M) 
Time, 
Minutes 
Im Abs.* 
(Peak @ 448 nm) 
2-MeIm Abs.* 
(Peak @ 445 nm) 
4-MeIm Abs.* 
(Peak @ 448 nm) 
0 0.24 0.28 0.27 
1.5 0.44 1.14 0.40 
3.0 0.70 1.33 0.55 
4.5 0.84 1.5 0.72 
6.0 0.87 1.73 0.86 
7.5 0.84 >2.00 1.08 
9.5 0.73 1.87 1.13 
11.5 0.63 1.75 1.17 
13.5 0.55 1.60 1.17 
16.5 0.47 1.26 1.15 
21.5 0.40 0.80 1.08 
31.5 0.33 0.60 0.54 
41.5 0.30 0.54 0.43 
61.5 0.29 0.48 0.42 
81.5 0.29 0.42 0.39 
101.5 0.28 0.40 0.39 
121.5 0.28 0.38 0.39 
* The Cary 14 utilizes a strip-chart recorder with strip-chart paper marked off for 
absorbance from 0.0 to 1.0.  Since the instrument can read in two ranges, the low 
range readings were taken from the charts with values of 0.0 – 1.0, and the high range 
readings were taken from the charts with values of 1.0 – 2.0. 
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                                             Appendix B: TableCurve Data Files 
 The following printouts are unaltered TableCurve scans of data plots from the 
data entered from the Cary 14 spectrometer stripcharts.  The Test Numbers on each 
printout correspond to the identification numbers in Tables 1 – 6 in the text. 
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